journal
MENU ▼
Read by QxMD icon Read
search

Journal of Clinical Psychopharmacology

journal
https://www.readbyqxmd.com/read/28328793/first-episode-psychosis-possibly-due-to-roxithromycin-related-inhibition-of-metabolization-of-tetrahydrocannabinol
#1
Maximilian Gahr, Christoph Hiemke, Bernhard J Connemann, Carlos Schönfeldt-Lecuona
No abstract text is available yet for this article.
March 21, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28328792/statistics-commentary-series-commentary-no-20-statistical-significance-and-practical-importance
#2
David L Streiner
No abstract text is available yet for this article.
March 21, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28328791/reflections-on-the-phases-of-the-moon-and-the-phases-of-drug-development
#3
Richard I Shader
No abstract text is available yet for this article.
March 21, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28328790/comparison-of-the-effects-of-quetiapine-xr-and-lithium-monotherapy-on-actigraphy-measured-circadian-parameters-in-patients-with-bipolar-ii-depression
#4
Jeong Yeon Hwang, Jae-Won Choi, Seung-Gul Kang, Su Hwan Hwang, Seog Ju Kim, Yu Jin Lee
PURPOSE/BACKGROUND: The aim of this study was to evaluate the effects of quetiapine XR and lithium on actigraphy-measured circadian parameters in patients with bipolar II depression. METHODS/PROCEDURES: This was an 8-week, open-label, prospective, randomized comparative study. The assessments included the 17-item Hamilton Depression Rating Scale score and actigraphic measures concerning the previous 7 days, collected at each visit (weeks 0 [baseline], 1, 2, 4, 6, and 8); the actigraphic data were analyzed with a cosinor analysis...
March 21, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28328789/clotiapine-monotherapy-in-a-patient-with-clozapine-resistant-schizophrenia
#5
Chia-Hung Lin, Hsien-Yuan Lane
No abstract text is available yet for this article.
March 21, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28306617/ciprofloxacin-associated-exacerbation-of-anxiety-in-an-elderly-patient-a-review-of-anxiogenic-potential-of-fluoroquinolones
#6
Sahil Munjal, Yvette Smolin
No abstract text is available yet for this article.
March 17, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28306616/optimal-dosing-of-risperidone-and-olanzapine-in-the-maintenance-treatment-for-patients-with-schizophrenia-and-related-psychotic-disorders-a-retrospective-multicenter-study
#7
Yusaku Yoshimura, Toshihiko Takeda, Yoshiki Kishi, Toshiki Harada, Akira Nomura, Kenji Washida, Bunta Yoshimura, Kojiro Sato, Yuji Yada, Shozo Aoki
OBJECTIVES: This study aims to determine the optimal tolerability dose ranges of risperidone (RIS) and olanzapine (OLZ) administered during schizophrenia maintenance phase. METHODS: Two-year continuation rates of prescription at discharge were examined using a retrospective cohort study method. Adult patients with schizophrenia and related psychotic disorders, receiving antipsychotic monotherapy with RIS or OLZ at discharge, were included. The primary outcome measures were the time to treatment discontinuation and 2-year continuation rates at 4 modal dose ranges of each drug...
March 17, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28301399/is-there-an-effect-of-methylphenidate-on-thrombocytopenia
#8
Eyüp Sabri Ercan, Sevim Berrin Inci, Melis Ipci
No abstract text is available yet for this article.
March 15, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28301398/a-pilot-study-cardiac-parameters-in-children-receiving-new-generation-antidepressants
#9
Mai Uchida, Andrea E Spencer, Tara Kenworthy, James Chan, Maura Fitzgerald, Ana Maria Rosales, Elana Kagan, Alexandra Saunders, Joseph Biederman
OBJECTIVE: Because of concerns about potential associations between high doses of citalopram and QTc prolongation in adults, this study examined whether such associations are operant in children. We hypothesized that therapeutic doses of nontricyclic antidepressant medications (non-TCAs) prescribed to children would be cardiovascularly safe. STUDY DESIGN: The sample consisted of 49 psychiatrically referred children and adolescents 6 to 17 years old of both sexes treated with a non-TCA (citalopram, escitalopram, fluoxetine, paroxetine, sertraline, bupropion, duloxetine, venlafaxine, mirtazapine)...
March 15, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28277401/zotepine-associated-hypothermia-in-a-schizophrenic-inpatient
#10
Ting-Ren Chen, Ying-Chang Chen, Wen-Chen Ouyang
No abstract text is available yet for this article.
March 9, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28277400/rectal-bioavailability-of-sertraline-tablets-in-a-critically-ill-patient-with-bowel-compromise
#11
Jonathan G Leung, Kemuel L Philbrick, Erica A Loomis, Erin Frazee
No abstract text is available yet for this article.
March 9, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28272088/methoxphenidine-use-disorder-first-case-notified-to-the-french-addictovigilance-network
#12
William Champeau, Céline Eiden, Julien Gambier, Hélène Peyriere
No abstract text is available yet for this article.
March 7, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28195931/should-antipsychotic-medications-for-schizophrenia-be-given-for-a-lifetime-a-naturalistic-long-term-follow-up-study
#13
Ira D Glick, John M Davis, Daisy Zamora, Jacob Ballon, Meena Nuthi
BACKGROUND: Schizophrenia remains a major health problem despite antipsychotic medications that, for most patients, can decrease acute symptoms, decrease relapses, and contribute to partial and sometimes strong positive response in patients with chronic symptoms. What has not been clear-because a double-blind, randomized, placebo-controlled trial is not feasible or ethical-is how many years after the initial episode, or onset of antipsychotic treatment, should medication be continued to achieve the best global outcome...
February 13, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28187007/clinicaltrials-gov-inhaled-loxapine-and-safety-issues
#14
Richard I Shader
No abstract text is available yet for this article.
February 10, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28181982/vilazodone-associated-hyperglycemia-in-a-patient-with-diabetes-a-case-report
#15
Anil Kumar Buruganahalli Nagendrappa
No abstract text is available yet for this article.
February 8, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28166082/differential-risk-of-peptic-ulcer-among-users-of-antidepressants-combined-with-nonsteroidal-anti-inflammatory-drugs
#16
Ju-Young Shin, Inmyung Song, Jin-Ho Lee, Jong Lull Yoon, Jun Soo Kwon, Byung-Joo Park
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) have been reported to have an increased risk of gastrointestinal adverse events, and the risk may be further increased by combined use of nonsteroidal anti-inflammatory drugs (NSAIDs). However, little has been known about the risk of peptic ulcer associated with other classes of antidepressants or individual antidepressants combined with NSAIDs. METHODS: We conducted a retrospective cohort study to define the risk of peptic ulcer associated with combined use of antidepressants and NSAIDs, as compared with use of antidepressants alone...
February 3, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28166081/the-art-of-pharmacotherapy-reflections-on-pharmacophobia
#17
Jose de Leon, Carlos De Las Cuevas
PURPOSE/BACKGROUND: This commentary deals with the neglected issue of the art of psychopharmacology by recounting the authors' journeys. METHODS/PROCEDURES: First, a model of medical science situated within the history of medicine is described including (1) a limitation of the mathematical model of science, (2) the distinction between mechanistic science and mathematical science, (3) how this distinction is applied to medicine, and (4) how this distinction is applied to explain pharmacology to psychiatrists...
February 3, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28146000/efficacy-of-desvenlafaxine-compared-with-placebo-in-major-depressive-disorder-patients-by-age-group-and-severity-of-depression-at-baseline
#18
Daniel Mosca, Min Zhang, Rita Prieto, Matthieu Boucher
PURPOSE: This post hoc meta-analysis evaluated the efficacy and safety of desvenlafaxine 50 and 100 mg versus placebo across age groups and severity of depression at baseline in patients with major depressive disorder. METHODS: Data from placebo and desvenlafaxine 50-mg and 100-mg dose arms were pooled from 9 short-term, placebo-controlled, major depressive disorder studies (N = 4279). Effects of age (18-40 years, >40 to <55 years, 55-<65 years, and ≥65 years) and baseline depression severity (mild, 17-item Hamilton Rating Scale for Depression total score [HAM-D17] ≤18; moderate, HAM-D17 >18 to <25; severe, HAM-D17 ≥25) on desvenlafaxine efficacy were assessed using analysis of covariance for continuous end points and logistic regression for categorical end points...
January 31, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28145998/long-acting-aripiprazole-in-comorbid-bipolar-disorder-and-borderline-personality-disorder-and-substance-abuse
#19
Jesús Salomón Martínez, Asur Rahuel Sánchez Caballero
No abstract text is available yet for this article.
January 31, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28141622/5-ht6-receptor-antagonist-as-an-adjunct-treatment-targeting-residual-symptoms-in-patients-with-schizophrenia-unexpected-sex-related-effects-double-blind-placebo-controlled-trial
#20
Margarita Morozova, Denis Burminskiy, George Rupchev, Taissia Lepilkina, Sergey Potanin, Allan Beniashvili, Yan Lavrovsky, Natalia Vostokova, Alexander Ivaschenko
BACKGROUND: Treating patients who experience residual psychotic symptoms during remission of schizophrenia remains one of the most challenging problems. The mechanisms underlying these symptoms differ from those of acute hallucinations and delusions. 5-HT6 receptor antagonists have been considered promising agents in treatment of residual psychotic symptoms and cognitive dysfunction. The aim of the study was to assess the efficacy of a selective 5-HT6 inhibitor Avisetron in the reduction of residual psychotic symptoms in patients with schizophrenia on stable antipsychotic therapy...
January 30, 2017: Journal of Clinical Psychopharmacology
journal
journal
28217
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"